CD4 T cell survival after intermittent interleukin-2 therapy is predictive of an increase in the CD4 T cell count of HIV-infected patients

Sarah W. Read, Richard A. Lempicki, Michele Di Mascio, Sharat Srinivasula, Rosanne Burke, William Sachau, Marjorie Bosche, Joseph W. Adelsberger, Irini Sereti, Richard T. Davey, Jorge A. Tavel, Chiung Yu Huang, Haleem J. Issaq, Stephen D. Fox, H. Clifford Lane, Joseph A. Kovacs

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'CD4 T cell survival after intermittent interleukin-2 therapy is predictive of an increase in the CD4 T cell count of HIV-infected patients'. Together they form a unique fingerprint.

Medicine & Life Sciences